增加的MCHC*RDW-SD相互作用值:中毒儿童神经功能障碍的指标
Qingji Ying1, Mengsi Ye1, Tingting Zhang2
1Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
PeerJ
|March 4, 2024
概括
增加的体质血红蛋白平均度 (MCHC) 和红细胞分布宽度标准偏差 (RDW-SD) 相互作用值可以作为可靠的生物标志物,用于检测中毒儿童的神经功能障碍.
科学领域:
- 儿科神经学 儿科神经学
- 毒理学 毒理学 毒理学
- 血液学 血液学 血液学
背景情况:
- 暴露于会对儿童发育中的神经系统造成显著的神经毒性风险.
- 长期的神经缺陷是儿童中毒的一个主要问题.
- 识别可访问的生物标志物对于监测引起的神经损伤至关重要.
研究的目的:
- 确定一种可靠且易于获得的生物标志物,用于中毒儿童的神经功能障碍.
- 评估红细胞参数在反映神经毒性的有效性.
主要方法:
- 分析了356名中毒儿童的血液学数据,并与健康对照进行了匹配.
- 使用多变量逻辑回归和接收器操作特征 (ROC) 分析.
- 研究了红细胞参数与神经功能障碍之间的关联.
主要成果:
- 在中毒儿童中观察到红细胞参数的显著变化.
- 平均体质血红蛋白度 (MCHC) 和红细胞分布宽度标准偏差 (RDW-SD) 的相互作用与神经功能障碍 (AUC=0.76) 有着强烈的关联.
- MCHC*RDW-SD相互作用值证明与其他红细胞参数独立.
结论:
- 建议MCHC*RDW-SD相互作用值作为中毒儿童神经障碍的强大和独立的生物标志物.
- 红细胞参数为查儿科患者中的神经毒性作用提供了一个有希望的途径.
- 这一发现支持使用可访问的血液学标记物用于早期检测和管理.
相关概念视频
Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Hepatic Encephalopathy
71
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
71


